PDIGREE Trial in Metastatic Untreated RCC

PDIGREE Trial in Metastatic Untreated RCC
Don Photo

Don
3 años 138 Puntos de vista
Categoría:
Descripción:
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the design on the outcomes of the PDIGREE trial in metastatic, untreated renal cell carcinoma.